PKO Investment Management Joint-Stock’s Pfizer PFE Stock Holding History

PKO Investment Management Joint-Stock’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.01M	Buy	166,450 +101,450	+156%	+$2.65M	0.29%	69
2026 Q1	$1.83M	Sell	65,000 -18,000	-22%	-$479K	0.15%	115
2025 Q4	$2.07M	Sell	83,000 -7,000	-8%	-$177K	0.16%	111
2025 Q3	$2.29M	Hold	90,000	–	–	0.2%	99
2025 Q2	$2.18M	Sell	90,000 -4,000	-4%	-$93.3K	0.23%	85
2025 Q1	$2.38M	Buy	94,000 +15,000	+19%	+$393K	0.27%	75
2024 Q4	$2.1M	Sell	79,000 -18,484	-19%	-$501K	0.26%	66
2024 Q3	$2.82M	Hold	97,484	–	–	0.35%	52
2024 Q2	$2.73M	Sell	97,484 -7,000	-7%	-$193K	0.34%	58
2024 Q1	$2.91M	Sell	104,484 -21,000	-17%	-$583K	0.35%	51
2023 Q4	$3.61M	Buy	125,484 +4,000	+3%	+$121K	0.45%	38
2023 Q3	$4.03M	Hold	121,484	–	–	0.55%	31
2023 Q2	$4.46M	Hold	121,484	–	–	0.55%	32
2023 Q1	$4.96M	Buy	121,484 +37,000	+44%	+$1.6M	0.65%	28
2022 Q4	$4.33M	Sell	84,484 -6,000	-7%	-$288K	0.63%	35
2022 Q3	$3.96M	Sell	90,484 -17,102	-16%	-$831K	0.67%	35
2022 Q2	$5.64M	Sell	107,586 -10,000	-9%	-$510K	0.81%	31
2022 Q1	$6.09M	Sell	117,586 -9,200	-7%	-$477K	0.74%	39
2021 Q4	$7.49M	Sell	126,786 -37,976	-23%	-$1.88M	0.84%	33
2021 Q3	$7.09M	Buy	164,762 +44,043	+36%	+$1.95M	0.85%	34
2021 Q2	$4.73M	Buy	120,719 +71,731	+146%	+$2.79M	0.59%	43
2021 Q1	$1.77M	Hold	48,988	–	–	0.28%	57
2020 Q4	$1.8M	Sell	48,988 -2,645	-5%	-$97K	0.31%	52
2020 Q3	$1.8M	Hold	51,633	–	–	0.35%	52
2020 Q2	$1.6M	Hold	51,633	–	–	0.36%	51
2020 Q1	$1.6M	Hold	51,633	–	–	0.54%	43
2019 Q4	$1.92M	Sell	51,633 -17,490	-25%	-$623K	0.48%	48
2019 Q3	$2.36M	Hold	69,123	–	–	0.6%	40
2019 Q2	$2.84M	Hold	69,123	–	–	0.72%	36
2019 Q1	$2.79M	Hold	69,123	–	–	0.73%	39
2018 Q4	$2.86M	Hold	69,123	–	–	0.81%	35
2018 Q3	$2.89M	Hold	69,123	–	–	0.58%	34
2018 Q2	$2.38M	Hold	69,123	–	–	0.5%	39
2018 Q1	$2.33M	Sell	69,123 -19,336	-22%	-$665K	0.52%	39
2017 Q4	$3.04M	Buy	88,459 +12,921	+17%	+$441K	0.76%	29
2017 Q3	$2.56M	Buy	75,538 +20,541	+37%	+$660K	0.69%	28
2017 Q2	$1.75M	Buy	54,997 +34,765	+172%	+$1.1M	0.59%	32
2017 Q1	$657K	Buy	20,232 +16,580	+454%	+$523K	0.3%	44
2016 Q4	$113K	Buy	+3,652	New	+$111K	0.07%	47

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PKO Investment Management Joint-Stock's PFE Position: Q2 2026 in Review

PKO Investment Management Joint-Stock increased its Pfizer (PFE) stake by 156% in Q2 2026, buying an estimated $2.65M and bringing the position to 166,450 shares worth $4.01M. The position accounts for 0.29% of the portfolio, ranked #69.

PKO Investment Management Joint-Stock first reported a position in PFE in Q4 2016 and has held it in 39 quarters since. The position peaked at $7.49M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

PKO Investment Management Joint-Stock held 166,450 shares of Pfizer worth $4.01M as of Q2 2026.
PKO Investment Management Joint-Stock bought 101,450 Pfizer shares in Q2 2026, an estimated $2.65M.
Pfizer made up 0.29% of PKO Investment Management Joint-Stock's portfolio in Q2 2026, its #69 holding.
PKO Investment Management Joint-Stock first reported a position in Pfizer in Q4 2016 and has held it in 39 quarters since.
PKO Investment Management Joint-Stock's Pfizer position peaked at $7.49M in Q4 2021.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2026, filed 20 Jul 2026.